Magnosco GmbH is a MedTech company based in Berlin, Germany, dedicated to advancing skin cancer diagnostics through innovative digital and non-invasive technologies. The company develops a smart, digital dermatoscope called 'Magnos' that combines laser technology and artificial intelligence to support early detection of malignant melanoma. Their solution includes a multi-touch display system, an iOS app for image documentation and patient communication, and a proprietary AI platform expected to launch by the end of 2025. Magnosco’s technology enables faster, more accurate skin lesion analysis, enhancing diagnostic confidence and patient engagement while contributing to improved survival rates through early intervention.